Bellevue Group AG
- SEC CIK
- 0001674546
- 最新申報
- 2026/8/14
2024 年第 4 季持倉
持倉截至 2024/12/31，2025/2/14 申報。只含多頭部位，變化是跟 2024 年第 3 季比股數。
- 持股檔數
- 160
- 較 2024 年第 3 季 −2
- 總值
- $51.9 億
- 較 2024 年第 3 季 −$9.77 億 (−15.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| TEMTempus AI, Inc. | CL A | 237 | $8,001 | <0.1% | −279−54.1% | 減碼 | 歷史 |
| LHLabcorp Holdings Inc. | Stock | 216 | $4.95 萬 | <0.1% | +10+4.9% | 加碼 | 歷史 |
| MTDMettler Toledo International Inc | COM | 42 | $5.14 萬 | <0.1% | +1+2.4% | 加碼 | 歷史 |
| QCOMQualcomm Inc | Stock | 447 | $6.87 萬 | <0.1% | +20+4.7% | 加碼 | 歷史 |
| MSFTMicrosoft Corp | Stock | 203 | $8.56 萬 | <0.1% | +9+4.6% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 41,500 | $9.75 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| NVDANVIDIA Corp | Stock | 751 | $10.1 萬 | <0.1% | +35+4.9% | 加碼 | 歷史 |
| AAgilent Technologies, Inc. | COM | 806 | $10.8 萬 | <0.1% | +37+4.8% | 加碼 | 歷史 |
| ORCLOracle Corp | Stock | 654 | $10.9 萬 | <0.1% | +30+4.8% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 13,600 | $11.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| VCYTVeracyte, Inc. | COM | 3,600 | $14.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 8,000 | $15.1 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 8,100 | $16.0 萬 | <0.1% | +8,100 | 新進 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 4,000 | $16.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| BIDUBaidu, Inc. | ADR | 2,000 | $16.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| OCSOculis Holding AG | ORDINARY SHARES | 10,000 | $17.0 萬 | <0.1% | +10,000 | 新進 | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 3,800 | $17.2 萬 | <0.1% | +3,800 | 新進 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 16,499 | $20.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| GRMNGarmin Ltd | SHS | 1,050 | $21.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 3,000 | $23.0 萬 | <0.1% | −1,000−25.0% | 減碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 4,400 | $23.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 3,200 | $27.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 24,000 | $28.4 萬 | <0.1% | +24,000 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 10,400 | $28.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 16,900 | $29.0 萬 | <0.1% | −9,000−34.7% | 減碼 | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 15,700 | $32.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 8,200 | $32.1 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| MRUSMerus N.V. | COM | 8,000 | $33.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 1,100 | $33.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ZLABZai Lab Ltd | ADR | 13,000 | $34.0 萬 | <0.1% | +13,000 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 2,500 | $34.4 萬 | <0.1% | +2,500 | 新進 | 歷史 |
| QUREuniQure N.V. | SHS | 22,500 | $39.7 萬 | <0.1% | +22,500 | 新進 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 23,100 | $40.2 萬 | <0.1% | −7,900−25.5% | 減碼 | 歷史 |
| BIIBBiogen Inc. | COM | 2,652 | $40.6 萬 | <0.1% | +18+0.7% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 10,941 | $51.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 12,939 | $52.1 萬 | <0.1% | −3,240−20.0% | 減碼 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 39,500 | $55.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 25,000 | $64.3 萬 | <0.1% | +17,300+224.7% | 加碼 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 5,047 | $79.1 萬 | <0.1% | +268+5.6% | 加碼 | 歷史 |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 100,414 | $79.5 萬 | <0.1% | +24,000+31.4% | 加碼 | 歷史 |
| VanEck ETF Trust92189F106 | GOLD MINERS ETF | 26,200 | $88.8 萬 | <0.1% | +26,200 | 新進 | – |
| PTGXProtagonist Therapeutics, Inc | COM | 23,718 | $91.6 萬 | <0.1% | +11,372+92.1% | 加碼 | 歷史 |
| BNTXBioNTech SE | SPONSORED ADS | 8,332 | $94.9 萬 | <0.1% | −389−4.5% | 減碼 | 歷史 |
| CVSCVS Health Corp | Stock | 21,844 | $98.1 萬 | <0.1% | −222−1.0% | 減碼 | 歷史 |
| CERTCertara, Inc. | COM | 92,129 | $98.1 萬 | <0.1% | −3,795−4.0% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 12,038 | $98.5 萬 | <0.1% | +57+0.5% | 加碼 | 歷史 |
| GOOGAlphabet Inc. | Stock | 6,000 | $114.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 23,596 | $132.1 萬 | <0.1% | +7,896+50.3% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 60,598 | $133.6 萬 | <0.1% | −10,223−14.4% | 減碼 | 歷史 |
| DOCSDoximity, Inc. | CL A | 27,911 | $149.0 萬 | <0.1% | −1,149−4.0% | 減碼 | 歷史 |
| RDYDr Reddys Laboratories Ltd | ADR | 97,900 | $154.6 萬 | <0.1% | −5,075−4.9% | 減碼依 5 比 1 拆股換算 | 歷史 |
| ZTSZoetis Inc. | Stock | 9,779 | $159.3 萬 | <0.1% | +4,495+85.1% | 加碼 | 歷史 |
| ACCDAccolade, Inc. | COM | 615,509 | $210.5 萬 | <0.1% | −25,356−4.0% | 減碼 | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 38,113 | $215.6 萬 | <0.1% | +1,288+3.5% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 35,700 | $233.9 萬 | <0.1% | +2,200+6.6% | 加碼 | 歷史 |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 377,806 | $255.4 萬 | <0.1% | −15,075−3.8% | 減碼 | 歷史 |
| CAHCardinal Health Inc | Stock | 22,298 | $263.7 萬 | 0.1% | −7,926−26.2% | 減碼 | 歷史 |
| BTSGBrightSpring Health Services, Inc. | COM | 174,152 | $296.6 萬 | 0.1% | +174,152 | 新進 | 歷史 |
| SMMTSummit Therapeutics Inc. | COM | 170,594 | $304.4 萬 | 0.1% | +106,500+166.2% | 加碼 | 歷史 |
| SPYSPDR S&P 500 ETF Trust | ETF | 5,660 | $331.7 萬 | 0.1% | +5,660 | 新進 | 歷史 |
| PFEPfizer Inc | Stock | 141,560 | $375.6 萬 | 0.1% | +485+0.3% | 加碼 | 歷史 |
| TXG10x Genomics, Inc. | CL A COM | 270,728 | $388.8 萬 | 0.1% | −11,153−4.0% | 減碼 | 歷史 |
| MASIMasimo Corp | COM | 24,166 | $399.5 萬 | 0.1% | +24,166 | 新進 | 歷史 |
| OMCLOmnicell, Inc. | COM | 94,740 | $421.8 萬 | 0.1% | −102,974−52.1% | 減碼 | 歷史 |
| GILDGilead Sciences, Inc. | Stock | 48,429 | $447.3 萬 | 0.1% | +2,402+5.2% | 加碼 | 歷史 |
| CNCCentene Corp | Stock | 86,456 | $523.8 萬 | 0.1% | −252−0.3% | 減碼 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 167,341 | $544.5 萬 | 0.1% | −1,793−1.1% | 減碼 | 歷史 |
| WAYWaystar Holding Corp. | COM | 157,898 | $579.5 萬 | 0.1% | +7,696+5.1% | 加碼 | 歷史 |
| ILMNIllumina, Inc. | COM | 43,703 | $584.0 萬 | 0.1% | −1,493−3.3% | 減碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,061,753 | $588.2 萬 | 0.1% | +19,618+1.9% | 加碼 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 34,229 | $632.2 萬 | 0.1% | −24,500−41.7% | 減碼 | 歷史 |
| ASTHAstrana Health, Inc. | COM NEW | 205,239 | $647.1 萬 | 0.1% | −48,943−19.3% | 減碼 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 945,446 | $681.7 萬 | 0.1% | +81,786+9.5% | 加碼 | 歷史 |
| HUMHumana Inc | Stock | 28,367 | $719.7 萬 | 0.1% | −73−0.3% | 減碼 | 歷史 |
| JNJJohnson & Johnson | Stock | 54,557 | $789.0 萬 | 0.2% | +3,315+6.5% | 加碼 | 歷史 |
| FATEFate Therapeutics Inc | COM | 4,839,779 | $798.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ABBVAbbVie Inc. | Stock | 45,259 | $804.3 萬 | 0.2% | +2,373+5.5% | 加碼 | 歷史 |
| IQVIQVIA Holdings Inc. | Stock | 44,833 | $881.0 萬 | 0.2% | −84,994−65.5% | 減碼 | 歷史 |
| GKOSGLAUKOS Corp | COM | 60,875 | $912.8 萬 | 0.2% | −2,108−3.3% | 減碼 | 歷史 |
| CRLCharles River Laboratories International, Inc. | COM | 50,327 | $929.0 萬 | 0.2% | −22,788−31.2% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 118,930 | $1,006 萬 | 0.2% | −248,251−67.6% | 減碼 | 歷史 |
| PHRPhreesia, Inc. | COM | 405,693 | $1,021 萬 | 0.2% | −16,713−4.0% | 減碼 | 歷史 |
| MCKMcKesson Corp | Stock | 19,315 | $1,101 萬 | 0.2% | −16,427−46.0% | 減碼 | 歷史 |
| BIOBio-Rad Laboratories, Inc. | CL A | 33,551 | $1,102 萬 | 0.2% | −12,600−27.3% | 減碼 | 歷史 |
| TMDXTransMedics Group, Inc. | COM | 192,718 | $1,202 萬 | 0.2% | +22,874+13.5% | 加碼 | 歷史 |
| SIBNSI-BONE, Inc. | COM | 880,979 | $1,235 萬 | 0.2% | −563,130−39.0% | 減碼 | 歷史 |
| EVHEvolent Health, Inc. | CL A | 1,113,658 | $1,253 萬 | 0.2% | −1,556,392−58.3% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 485,050 | $1,315 萬 | 0.3% | −144,708−23.0% | 減碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 110,230 | $1,391 萬 | 0.3% | +104,605+1,859.6% | 加碼 | 歷史 |
| ELVElevance Health, Inc. | Stock | 38,343 | $1,414 萬 | 0.3% | −50,985−57.1% | 減碼 | 歷史 |
| NEONeogenomics Inc | COM NEW | 1,055,796 | $1,740 萬 | 0.3% | −556,816−34.5% | 減碼 | 歷史 |
| EHCEncompass Health Corp | COM | 188,522 | $1,741 萬 | 0.3% | +169,289+880.2% | 加碼 | 歷史 |
| CORCencora, Inc. | Stock | 77,522 | $1,742 萬 | 0.3% | +5,469+7.6% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 258,483 | $1,785 萬 | 0.3% | −266,951−50.8% | 減碼 | 歷史 |
| HOLXHologic Inc | COM | 247,886 | $1,787 萬 | 0.3% | +220.0% | 加碼 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 8,517,839 | $1,823 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| HCAHCA Healthcare, Inc. | COM | 61,883 | $1,857 萬 | 0.4% | −52,642−46.0% | 減碼 | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 953,164 | $1,863 萬 | 0.4% | −106,007−10.0% | 減碼 | 歷史 |
| CSTLCastle Biosciences Inc | COM | 745,982 | $1,988 萬 | 0.4% | −516,048−40.9% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 171,317 | $2,083 萬 | 0.4% | −173,031−50.2% | 減碼 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| Moderna Inc60770K907 | CALL | – | $11.0 萬 |
2024 年第 3 季之後清倉（14 檔）
2024 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 3 季股數 | 2024 年第 3 季市值 | 2024 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| OPCHOption Care Health, Inc. | COM NEW | 1,654,878 | $5,180 萬 | 0.8% | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 7,879,583 | $4,775 萬 | 0.8% | 歷史 |
| EXELExelixis, Inc. | COM | 1,600,000 | $4,152 萬 | 0.7% | 歷史 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 610,000 | $2,866 萬 | 0.5% | 歷史 |
| GBIOGeneration Bio Co. | COM | 3,918,856 | $968.0 萬 | 0.2% | 歷史 |
| MTEMMolecular Templates, Inc. | COM NEW | 1,279,820 | $179.8 萬 | <0.1% | 歷史 |
| SNYSanofi | SPONSORED ADR | 15,109 | $87.1 萬 | <0.1% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 19,046 | $54.9 萬 | <0.1% | 歷史 |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 24,015 | $46.9 萬 | <0.1% | 歷史 |
| VTRSViatris Inc | Stock | 39,283 | $45.6 萬 | <0.1% | 歷史 |
| NKENIKE, Inc. | Stock | 3,500 | $30.9 萬 | <0.1% | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 7,200 | $22.8 萬 | <0.1% | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 9,300 | $17.2 萬 | <0.1% | 歷史 |
| OABIOmniAb, Inc. | COM | 11,456 | $4.85 萬 | <0.1% | 歷史 |